US filing analysis · 10-Q
Sorted by SEC acceptance time (filing date when unavailable). Page 23 · 30 shown · up to 30 per page
VRTX
Vertex Pharmaceuticals said net product revenues for Q2 2025 increased to $2.9 billion from $2.6 billion in Q2 2024, citing continued strong patient demand for TRIKAFTA/KAFTRIO and early contributions from three ongoing launches.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Vertex PharmaceuticalsVRTX$515.02-1.08%
TDG
TransDigm said that for Q3 of fiscal 2025, it generated net sales of $2,237 million, net income attributable to TD Group of $492 million, and EBITDA As Defined of $1,217 million, or 54.4% of net sales.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
TransDigm GroupTDG$1,121.22-3.23%
SWKS
Skyworks Solutions said net revenue for the 3 months ended June 27, 2025 was $965.0 million, an increase from $905.5 million in the corresponding period of fiscal 2024, driven primarily by increased demand for its mobile and Wi-Fi products.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Skyworks SolutionsSWKS$73.98-5.95%
RVTY
Revvity said revenue for Q2 2025 ended June 29, 2025 was $720.3 million, an increase of $28.6 million, or approximately 4%, compared to the same period in the prior year. Life Sciences segment revenue was $365.9 million and Diagnostics segment revenue was $354.4 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
RevvityRVTY$145.22-4.20%
PFE
Pfizer said total revenues for Q2 2025 were $14.7 billion, an increase of $1.4 billion, or 10%, from $13.3 billion in the prior-year period. The impact of foreign exchange was de minimis, and the operational increase was $1.3 billion, or 10%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
PfizerPFE$27.4-0.51%
PEG
The company estimated its regulated capital investment program for 2025 to 2029 at $21 billion to $24 billion and said it expects its regulated rate base to grow at a compound annual rate of 6% to 7.5%. Its total capital investment program is $22.5 billion to $26 billion.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Public Service Enterprise GroupPEG$73.9-0.28%
OKE
ONEOK said it completed the Delaware Basin JV Acquisition on May 28, 2025 for $927 million, paying $536 million in cash and issuing approximately 4.9 million shares of ONEOK common stock with a fair value of $391 million as of the closing date. In the EnLink Acquisition completed on January 31, the company issued 41 million shares of common stock with a fair value of $4.0 billion as of the closing date.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
ONEOKOKE$84.37-2.48%
MPC
Marathon Petroleum said net income attributable to MPC decreased $299 million in Q2 2025 compared to Q2 2024 and $1.31 billion in the first six months of 2025 compared to the first six months of 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Marathon PetroleumMPC$370.77+0.77%
LDOS
Leidos said that as of July 4, 2025, the enactment of the OBBBA resulted in a decrease of $150 million to income taxes payable and a decrease of $130 million to deferred tax assets. The company estimated that the fiscal 2025 impact will result in a decrease of approximately $280 million to income taxes payable and a decrease of approximately $245 million to net deferred taxes.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
LeidosLDOS$122.21-2.04%
JPM
JPMorgan Chase reported net income of $15.0 billion for Q2 2025, down 17%, with earnings per share of $5.24, ROE of 18% and ROTCE of 21%. The results included an income tax benefit of $774 million in Corporate.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
JPMorgan ChaseJPM$310.53-3.03%
J
Jacobs Solutions said revenues for Q3 of fiscal 2025 were $3.03 billion, an increase of $148.4 million or 5.1%, and revenues for the 9 months were $8.88 billion, an increase of $334.3 million or 3.9%. The company cited revenue growth in its I&AF business and PA Consulting business as factors for the increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Jacobs SolutionsJ$150.62-2.56%
IT
Gartner said total revenues for Q2 2025 were $1.7 billion, an increase of 6% compared to the same period in the prior year, and net income was $240.8 million, compared to $229.5 million in the prior-year period. By segment, Insights revenues increased 4%, Conferences revenues increased 14% and Consulting revenues increased 9%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
GartnerIT$174.49+1.27%
HSIC
Henry Schein said internally generated local currency sales increased 1.9% for the quarter ended June 28, 2025. Global Technology net sales increased 7.4%, with internally generated local currency growth of 6.6%, the company said.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Henry ScheinHSIC$83.5-1.53%
GNRC
Generac said Domestic segment total sales, including inter-segment sales, increased 8% to $1,666.8 million for the 6 months ended June 30, 2025, and gross profit margin was 39.4%, compared to 36.7% in the prior-year comparable period.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
GeneracGNRC$193.22-5.79%
FIS
Fidelity National Information Services said it agreed to acquire Global Payments' Issuer Solutions business for an enterprise value of $13.5 billion, with a net purchase price of $12.0 billion, and to sell all of its equity interests in Worldpay to Global Payments for a pre-tax value of $6.6 billion, with the remainder of the purchase price to be paid in cash.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Fidelity National Information ServicesFIS$25.83-0.42%
DVA
DaVita said that during Q2 2025 it experienced a cybersecurity incident that resulted in a temporary disruption of its operations, and incurred charges of approximately $13.5 million to remediate the incident and restore systems. Patient care costs increased by $1.0 million and general and administrative expenses increased by $12.5 million. The company added that these costs do not include the impact related to business interruption on its results.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
DaVitaDVA$161.03+3.00%
DUK
Duke Energy said GAAP reported EPS for the 3 months ended June 30, 2025 was $1.25, compared to $1.13 in the prior year, and adjusted EPS was $1.25, compared to $1.18 in the prior year. The company cited the implementation of new rates and riders as drivers of the adjusted EPS increase, partially offset by higher operation and maintenance expense and interest expense.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Duke EnergyDUK$129.78+0.71%
DD
DuPont said net sales for the 3 months ended June 30, 2025 were $3.3 billion, up 3% from $3.2 billion in the same period of 2024, due to a 4% increase in volume and a 1% currency impact, partially offset by a 2% decrease in local price and product mix.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
DuPontDD$145.43-2.85%
BAX
Baxter said net income attributable to Baxter stockholders for the 3 months ended June 30, 2025 was $91 million, or $0.18 per diluted share, compared to $(314) million in the prior year period. Special items adversely impacted this amount by $185 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Baxter InternationalBAX$25.390.00%
BALL
Ball said net sales for the 3 months ended June 30, 2025 increased $379 million compared to the same period in 2024. The company cited higher volume of $224 million, price/mix of $127 million, mainly from higher aluminum prices, and currency translation of $53 million as factors.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Ball CorporationBALL$63.490.00%
AXON
Axon Enterprise said revenues for the 3 months ended June 30, 2025 were $668.5 million, an increase of $165.3 million, or 32.8%, from the prior year period. The company had a loss from operations of $1.0 million in the period, compared to income from operations of $33.8 million in the same quarter of the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Axon EnterpriseAXON$291.37-5.09%
AFL
Aflac said total revenues for Q2 2025 were $4.2 billion, compared with $5.1 billion for Q2 2024, and net earnings were $599 million, or $1.11 per diluted share, compared with $1.8 billion, or $3.10 per diluted share, for Q2 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
AflacAFL$124.32-0.35%
ADM
Archer-Daniels-Midland said earnings before income taxes for the quarter ended June 30, 2025 decreased $317 million from $596 million to $279 million, citing asset impairment, exit, and restructuring costs pursuant to the Company's portfolio optimization initiatives as the primary driver. The company said gross profits were consistent with the prior year quarter.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 5, 2025
Archer-Daniels-MidlandADM$66.95-0.27%
ACGL
Arch Capital said its annualized net income return on average common equity for Q2 2025 was 22.9% and its Operating ROAE was 18.2%. Book value per share increased from $55.15 at March 31, 2025 to $59.17 at June 30, a 7.3% increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 5, 2025
Arch Capital GroupACGL$108.87+0.66%
WRB
The company said the consolidated loss ratio for Q2 2025 was 63.1% compared with 62.6% in 2024. The expense ratio was 28.5% in both years, and policy acquisition and insurance operating expenses and net premiums earned each increased 9% from 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 4, 2025
W. R. BerkleyWRB$78.31+1.18%
WMB
Williams said net income attributable to The Williams Companies, Inc. for the 6 months ended June 30, 2025 increased $204 million compared to the prior-year period.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 4, 2025
Williams CompaniesWMB$64.31-2.75%
WAT
Waters said on July 13, 2025 it entered into definitive agreements with BD regarding a Reverse Morris Trust transaction valued at approximately $17.5 billion relating to BD's Biosciences and Diagnostic Solutions business, and that upon completion of the Merger, BD shareholders are expected to own approximately 39.2% of the combined company and existing Waters shareholders are expected to own approximately 60.8%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 4, 2025
WatersWAT$440.45-3.51%
TSN
Tyson Foods said sales for Q3 of fiscal 2025 grew 4%, or $531 million, and operating income was $260 million, down 24% from the same period in the prior year. The company cited greater operating losses in its Beef segment as a factor in the decline in operating income.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 4, 2025
Tyson FoodsTSN$65.12+1.97%
REG
On May 13, 2025, Regency Centers issued $400 million of senior unsecured notes due 2032 at a par value of 99.279% and a coupon of 5.0%. The company said the intended use of the net proceeds includes reducing the outstanding balance on the Line, repaying $250 million of 3.90% unsecured public debt due November 1, 2025 upon its maturity, and general corporate purposes.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Aug 4, 2025
Regency CentersREG$73.69-0.47%
PGR
Progressive said it wrote $20.1 billion of net premiums written in Q2 2025, which was $2.2 billion more than it generated in the same period last year. The underwriting profit margin for the quarter was 13.8%, compared to 8.1% in the prior-year quarter.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Aug 4, 2025
ProgressivePGR$231.39+0.62%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.